Search

Your search keyword '"Thomaidis, Thomas"' showing total 171 results

Search Constraints

Start Over You searched for: Author "Thomaidis, Thomas" Remove constraint Author: "Thomaidis, Thomas"
171 results on '"Thomaidis, Thomas"'

Search Results

2. Convolutional Neural Networks for Optical Discrimination Between Histological Types of Colorectal Polyps Based on White Light Endoscopic Images

4. ACCURACY OF CONVOLUTIONAL NEURAL NETWORKS FOR THE HISTOLOGIC CHARACTERIZATION OF COLORECTAL POLYPS USING CURRENTLY WIDESPREAD WHITE LIGHT ENDOSCOPY IN RESPECT TO ENDOSCOPIC AND HISTOPATHOLOGIC EVALUATION

5. Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker program

6. Lapatinib with ECF/X in the first-line treatment of metastatic gastric cancer according to HER2neu and EGFR status: a randomized placebo-controlled phase II study (EORTC 40071)

12. Predictive Value of Preoperative Endoscopic Ultrasound (EUS) After Neoadjuvant Chemotherapy in Locally Advanced Esophagogastric Cancer – Data From a Randomized German Phase II Trial

14. CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset

15. The Addition of Transarterial Chemoembolization to Palliative Chemotherapy Extends Survival in Intrahepatic Cholangiocarcinoma

19. Terminal Ileitis due to Yersinia Infection: An Underdiagnosed Situation

22. Additional file 1: of Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker program

23. Additional file 2: of Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker program

25. Optimal design of flexible & reliable process systems

27. Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction

28. Supp_1 – Supplemental material for Cytokeratin-18 fragments predict treatment response and overall survival in gastric cancer in a randomized controlled trial

29. Tu1476 – Afatinib Combined with Gemcitabine/Cisplatin in Chemotherapy Naive Patients with Advanced Biliary Tract Cancer: Results and Translational Analysis of an Open-Label, Phase I Trial

30. Su1129 – Predictive Significance of Endosonographic (EUS) Staging in Locally Advanced Gastric (GC) Or Gastroesophagealjunction (AEG) Adenocarcinoma: Analysis of Data from a Perioperative Aio-Cao Phase Ii Study

32. Cytokeratin-18 fragments predict treatment response and overall survival in gastric cancer in a randomized controlled trial

34. Endoscopic removal of an extraluminal gastrointestinal stromal tumor recurrence located on the surgical stapler line at gastroesophageal junction.

39. Correction: Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA)

40. LRP4 antibodies are frequent in serum and CSF from amyotrophic lateral sclerosis patients (S34.004)

42. Observational Study Assessing Demographic, Economic and Clinical Factors Associated with Access and Utilization of Health Care Services of Patients with Multiple Sclerosis under Treatment with Interferon Beta-1b (EXTAVIA)

43. Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial

44. Antibodies to LRP4 in serum and CSF from amyotrophic lateral sclerosis patients

45. Inclusion of targeted therapies in the standard of care for metastatic colorectal cancer patients in a German cancer center: the more the better?!

46. VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

47. Sa1909 Predictive Value of Proteins Related With the VEGFR and EGFR Pathways in Patients With Stage II/III Colorectal Cancer Receiving Adjuvant Treatment With Fluorouracil, Leucovorin +/− Irinotecan: Translational Results of the FOGT-4 Trial

49. Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction

50. LRP 4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients

Catalog

Books, media, physical & digital resources